(Press-News.org) Planned birth at term reduces the incidence of pre-eclampsia in women at high risk of the condition, without increasing emergency Caesarean or neonatal unit admission, according to new trial results.
The PREVENT-PE trial, led by researchers from King’s College London and King’s College Hospital NHS Foundation Trust, is the first to find that a strategy of screening for pre-eclampsia risk at 36 weeks of pregnancy, and then offering planned early term delivery according to the mother’s risk, can reduce the incidence of subsequent pre-eclampsia by 30%, compared with usual care.
The trial, funded by the Fetal Medicine Foundation (FMF), also found that the intervention did not increase the rates of birth by emergency Caesarean or neonatal care needs, and there was no evidence of other harms to mother or baby.
The findings were published today in The Lancet.
Pre-eclampsia is high blood pressure that develops during pregnancy, most commonly at term gestational age. Pre-eclampsia affects 2-8% of pregnancies worldwide and can be life-threatening – there are around 46,000 maternal deaths due to pre-eclampsia each year and around 500,000 foetal or newborn deaths.1
Pre-eclampsia usually develops after 20 weeks of pregnancy, or soon after the baby is born. While aspirin can be taken to significantly reduce the risk of developing pre-eclampsia before 37 weeks of pregnancy, there are no treatments available to reduce risk at term (37-42 weeks).
Building on findings from an earlier data analysis, the PREVENT-PE trial recruited over 8,000 women from King’s College Hospital and Medway NHS Foundation Trusts. Women were randomly allocated into one of two groups: the intervention group (risk assessment for pre-eclampsia, followed by planned early term delivery according to risk) and the control group (usual care at term).
Pre-eclampsia risk was assessed using a model developed by the FMF, which combines maternal demographics and history, with blood pressure, and specific markers in the blood.
Those at high risk of developing pre-eclampsia at term were offered planned birth at 37, 38, 39 or 40 weeks of pregnancy. Women considered to be at low risk received usual care, according to their hospital protocols and UK standards of care.
Professor Kypros Nicolaides, founder and chairman of the Fetal Medicine Foundation, and senior author of the paper, said: “A 30% reduction in term pre-eclampsia, from 5.6% to 3.9%, is very important. It represents an even greater reduction in the number of pre-eclampsia cases than we can achieve for preterm pre-eclampsia with aspirin.”
Dr Argyro Syngelaki, Reader in Maternal-Fetal Medicine at King’s College London and co-lead author of the paper, said: “This trial took place in busy NHS maternity units serving a highly diverse population, and often socially deprived communities where the burden of pre-eclampsia is greatest. The high level of participation and adherence shows that a personalised, risk-based approach is acceptable, practical, and aligns with what women want from their care. Achieving a 30% reduction in term pre-eclampsia, without increasing emergency Caesarean birth or neonatal admissions, represents a meaningful and reassuring improvement for women, babies, and maternity services.”
Professor Laura A. Magee, Professor of Women's Health at King’s College London and co-author of the paper, said: “We will soon report on the health economic implications of the trial, as well as the experiences of women and staff who participated, to provide policy-makers with the information that they need to implement the trial intervention within the NHS.”
Read the full paper in The Lancet: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01207-3/fulltext
References:
World Health Organization (2025). Pre-eclampsia. Available at: https://www.who.int/news-room/fact-sheets/detail/pre-eclampsia (2 July 2025) END
Planned birth at term reduces pre-eclampsia in those at high risk
2025-12-05
ELSE PRESS RELEASES FROM THIS DATE:
Penguins starved to death en masse, study warns, as some populations off South Africa estimated to have fallen 95% in just eight years
2025-12-05
Penguins living off the coast of South Africa have likely starved to death en masse during their moulting season as a result of collapsing food supplies.
In fact, on two of the most important breeding colonies of the African penguin (Spheniscus demersus) — Dassen Island and Robben Island — some 95% of the birds that bred in 2004 were estimated to have died over the next eight years as a result of food scarcity.
This is the conclusion of a new study ...
New research explains how our brains store and change memories
2025-12-05
A study from the University of East Anglia is helping scientists better understand how our brains remember past events - and how those memories can change over time.
A new paper published today explores episodic memory - the kind of memory we use to recall personal experiences like a birthday party or a holiday.
The team say their work has important implications for mental health, education, and legal settings where memory plays a key role.
Working collaboratively with the University of Texas in Dallas, the team show that memories aren’t just stored like files in a computer.
Instead, they’re ...
Space shuttle lessons: Backtracks can create breakthroughs
2025-12-04
What does the space shuttle have in common with the original iPhone? According to Francisco Polidoro Jr., professor of management of Texas McCombs, they’re both breakthrough inventions that integrate webs of interdependent features.
In an iPhone, he notes, its size, weight, camera, and Wi-Fi capabilities influence one another. Push one feature too far, and the phone becomes heavier, bulkier, or more expensive.
Companies can’t test each feature in isolation, and they can’t experiment ...
New study finds cystic fibrosis drug allows patients to safely scale back lung therapies
2025-12-04
A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the triple-drug therapy elexacaftor/tezacaftor/ivacaftor (ETI) can safely reduce many of their daily lung treatments while maintaining good health for years.
The study was published today in the Journal of Cystic Fibrosis.
“This is incredibly meaningful for individuals and families living with CF,” said lead author Scott Sagel, MD, PhD, professor of pediatrics-pulmonary medicine at the CU Anschutz School of Medicine and director of the University of Colorado Cystic Fibrosis Center. “For ...
From field to lab: Rice study reveals how people with vision loss judge approaching vehicles
2025-12-04
From field to lab: Rice study reveals how people with vision loss judge approaching vehicles
Despite impaired central vision, participants relied on both vision and audition, offering new insight into mobility and safety
Patricia DeLucia has spent decades studying something many of us never think about: judgments about collision that are crucial for safety. But the roots of her research stretch back to her childhood, long before she became a professor of psychological sciences at Rice University.
“I grew up playing sports, and when you’re on the field, collision judgment is everything — whether a ball is coming at you, whether ...
Study highlights underrecognized link between kidney disease and cognitive decline
2025-12-04
HUNTINGTON, W.Va. – A new study published in the American Journal of Physiology - Heart and Circulatory Physiology reveals that chronic kidney disease (CKD) accelerates cognitive decline through interconnected damage to the heart and brain—and that these pathways differ markedly between men and women.
Scientists and physicians from the Marshall University Joan C. Edwards School of Medicine, in collaboration with the National Institute on Aging at the National Institutes of Health (NIH), led the study to better understand sex-specific ...
Researchers find link between psychosocial stress and early signs of heart inflammation in women
2025-12-04
Women who report high levels of psychosocial stress, such as from caregiving and lack of emotional support, show signs of early heart tissue changes associated with cardiovascular disease – an association not observed in men, a new study reveals.
The results support the notion that there are sex-specific ways in which stress affects cardiovascular health and that risk-assessment processes should take psychosocial factors and mental wellness into account, the researchers said.
“From an epidemiological point of view, we have known for about two decades that stress is an important risk factor in cardiovascular health for people born female. But with this research ...
Research spotlight: How long-acting injectable treatment could transform care for postpartum women with HIV
2025-12-04
Q: How would you summarize your study for a lay audience?
For breastfeeding women who have HIV, consistently taking antiretroviral therapy (ART) is essential for their own health and the health of their infants. New long-acting (LA) injectable ART options, such as LA cabotegravir with rilpivirine (CAB/RPV), can help women suppress the HIV virus within their bodies — keeping them healthy and reducing transmission to their infants. Instead of daily oral pills, the injection is received every two months, making it easier for women to sustain treatment during the postpartum period and keep their medical diagnoses private.
Our study focused ...
Preempting a flesh-eating fly’s return to California
2025-12-04
The last time the New World screwworm invaded the U.S., it devastated livestock and required a decades-long eradication campaign. Now, University of California Riverside researchers are launching a preemptive strike against the parasitic fly’s threatened return.
The New World screwworm isn’t a worm at all. It’s the larval or maggot stage of a shiny, metallic blowfly, a species called Cochliomyia hominivorax. While many blowflies are harmless and play a vital role in decomposing dead animals, this particular species feeds on living flesh.
“Not all blowflies are this species. We don’t ...
Software platform helps users find the best hearing protection
2025-12-04
HONOLULU, Dec. 4, 2025 — The world is loud. A walk down the street bombards one’s ears with the sound of engines revving, car horns blaring, and the steady beeps of pedestrian crossings. While smartphone alerts to excessive sound and public awareness of noise exposure grows, few tools help people take protective action.
To address this gap, Santino Cozza and a team from Applied Research Associates, Inc. developed the Hearing Protection Optimization Tool (HPOT). HPOT was designed to move beyond traditional noise reductions ratings and highlight performance characteristics that ...